Improving the Safety of Angioplasty in Patients with Coronary Bypass Graft Disease
Monday, October 22, 2012 - 08:02
in Health & Medicine
(PHILADELPHIA) - Researchers at Thomas Jefferson University Hospital have shown that combining distal protection devices with the prophylactic use of the drug nicardipine is more effective at preventing life-threatening complications following a percutaneous coronary intervention (PCI) (angioplasty, stenting) on patients who have undergone previous bypass surgery than distal protection devices alone.